TruScreen looks across Tasman for new money

TruScreen looks across Tasman for new money
Dan Brunskill
TruScreen wants to raise as much as $2 million in a secondary listing on the ASX to attract Australian retail and biotech investors.The cervical cancer screening company said it will apply for an ASX foreign exempt listing to quote up to 28.5 million shares newly issued at 7 cents each. It currently has about 332.4 million shares issued. The shares are separated into two geographic pools, with 14.2 million for Australians and 7.1 million for New Zealanders.This would raise $1.5 million but TruScreen will accept up to $500,000 of oversubscr...